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The recording and characteristics of pulmonary rehabilitation
in patients with COPD using The Health Information Network
(THIN) primary care database
Ali Hakamy1,2, Tricia M. McKeever2, Jack E. Gibson2 and Charlotte E. Bolton 1
Pulmonary rehabilitation is recommended for patients with COPD to improve physical function, breathlessness and quality of life.
Using The Health Information Network (THIN) primary care database in UK, we compared the demographic and clinical parameters
of patients with COPD in relation to coding of pulmonary rehabilitation, and to investigate whether there is a survival beneﬁt from
pulmonary rehabilitation. We identiﬁed patients with COPD, diagnosed from 2004 and extracted information on demographics,
pulmonary rehabilitation and clinical parameters using the relevant Read codes. Thirty six thousand one hundred and eighty nine
patients diagnosed with COPD were included with a mean (SD) age of 67 (11) years, 53% were male and only 9.8% had a code
related to either being assessed, referred, or completing pulmonary rehabilitation ever. Younger age at diagnosis, better
socioeconomic status, worse dyspnoea score, current smoking, and higher comorbidities level are more likely to have a record of
pulmonary rehabilitation. Of those with a recorded MRC of 3 or worse, only 2057 (21%) had a code of pulmonary rehabilitation.
Survival analysis revealed that patients with coding for pulmonary rehabilitation were 22% (95% CI 0.69–0.88) less likely to die than
those who had no coding. In UK THIN records, a substantial proportion of eligible patients with COPD have not had a coded
pulmonary rehabilitation record. Survival was improved in those with PR record but coding for other COPD treatments were also
better in this group. GP practices need to improve the coding for PR to highlight any unmet need locally.
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INTRODUCTION
Pulmonary rehabilitation (PR) has become ﬁrmly established as a
core management strategy in patients with chronic obstructive
pulmonary disease (COPD).1–3 Ever since the National Institute for
Health and Clinical Excellence (NICE) guidelines for COPD in the
UK were issued in 2004,4 PR has been recommended, a ﬁnding
further reiterated in the 2013 British Thoracic Society (BTS) NICE
accredited pulmonary rehabilitation guidelines.1,2
The primary beneﬁts of PR include improving exercise
tolerance, dyspnoea, and quality of life with the strongest
evidence for its role in patients with COPD and with an MRC
breathlessness score of 3 or worse.1 The decision to refer to PR
should not be based on parameters such as age or comorbidities
but rather on disability and functional limitation.1,2,5,6 Co-
morbidities in patients with COPD are recognised, impacting
hugely on morbidity and mortality,7,8 but patients with co-
morbidities gain beneﬁt from PR and hence are not outright
exclusions.9,10
There is increasing interest in provision of PR across the UK with
the ongoing work of the National COPD audit programme:
pulmonary rehabilitation workstream. Maps of PR sites have now
been produced11 and a greater understanding of the unmet need
is emerging. There remains a poor understanding of referral
patterns into PR programme. A recent primary care snapshot audit
of COPD in Wales, UK also conﬁrmed low numbers of patients
referred to PR.12
COPD is punctuated by acute exacerbations that often require
hospitalisation which is known to be associated with signiﬁcant
mortality in COPD.13 A recent Cochrane review found that
participating in a PR programme after an acute exacerbation
reduces hospital admission and improves overall survival in
patients with COPD.14 However, information regarding survival
following the more common, usual PR is limited.15,16 One of the
objectives of a PR programme is to improve physical activity.1
Increased levels of physical activity itself is beneﬁcial for survival.17
We used a large UK primary care research database to identify
patients with COPD, their record of pulmonary rehabilitation,
demographics, and clinical characteristics. Survival rate according
to pulmonary rehabilitation recording were also investigated.
RESULT
Descriptive analysis
Thirty six thousand six hundred and ﬁfty seven patients had a
diagnosis of COPD that was made after January 1, 2004. With
further exclusions as detailed above, this resulted in a study
population of 36,189 [Fig. 1]. Of these, 19,354 (53%) were male,
with a mean (SD) age at diagnosis of 66.9 (11.4) years, while 18,680
(51.6%) were ex-smokers. 6602 (18.2%) patients had no record of
the MRC score and 10,667 (36%) of those who had a record of
MRC score, had a score of 3 or worse.
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There were 3542 patients (9.8%) with a recorded PR code,
30,982 (85.6%) with no recorded PR code of any sort, and 1665
(4.6%) with a declined PR code (and there was no other code of
subsequently going or being referred). Of those patients who
reported MRC 3 or worse (9750 patients), 7693 (81.8%) did not
have a record of PR. The median time from the date of diagnosis
to the ﬁrst PR record date was 875 days (interquartile range
271–1756).
Recorded PR group to not recorded PR
In comparing the recorded PR group to the not recorded group
(3542 vs. 30,982 patients) [Table 1], older patients (≥71 years old)
at diagnosis were less likely to have a record of PR than younger
patients (51–60 years old), with an adjusted Odds Ratio (aOR) of
0.60 (95% CI 0.53–0.76). The most deprived patients (Townsend
quintile 5) were less likely to have a record of PR than the least
deprived ones (Townsend quintile 1), aOR 0.61 (95% CI 0.54–0.70).
Two thousand and ﬁfty seven patients (21.1%) with MRC of 3 or
worse had a record of PR. Patients with the worse MRC score were
more likely to have a record of PR than those with a better score.
Current smokers were more likely to have a record of PR
compared with ex-smokers; aOR 2.60 (95% CI 2.41–2.86). Patients
with a higher Charlson comorbidity index (four or greater) were
more likely to have a record of PR than those with a lower index
(1); aOR 10.44 (95% CI 9.17–12.23).
Provision of ﬂu vaccination and smoking cessation advice to
smokers was also better in those with recorded PR than not PR: Flu
vaccination: 58 vs. 48% (aOR 1.42; 95% CI, 1.31–1.53); Smoking
cessation to smokers 77 vs. 52% (aOR 2.90; 95% CI, 2.52–3.34).
Declined PR group to recorded PR
Table 2 shows the unadjusted and adjusted odds ratio of the
declined PR group compared to the recorded PR group (1665 vs.
3542 patients). The patients’ age at diagnosis was associated with
a code of declining PR; 71 years and older were more likely to
have a record of declining PR than 51–60 years old, aOR 1.22 (95%
CI, 1.03–1.46). There was no difference between those who decline
PR and those with a recording for gender or the Charlson
Comorbidities Index. Socioeconomic deprivation was strongly
associated with recording of declining PR; the most deprived
(Townsend quintile 5) patients were more likely to record
declining PR than the least deprived ones (Townsend quintile 1),
aOR 1.81; (95% CI, 1.46–2.25). Patients with a worse MRC score
were less likely to have a record of declining PR than those with a
better score. Current smokers were more likely to have a record of
declining PR than ex-smokers, aOR 1.38; (95% CI, 1.21–1.58).
Survival analysis
In the abridged period of COPD diagnosis for the survival analysis
in order to allow follow-up time, 27,388 patients were included in
this analysis: 53% were male, mean (SD) age at diagnosis was 67
(11) years, 50.5% ex-smokers, and 11% with Charlson Comorbidity
Index of four or greater; which was similar to the full population.
Patients with a record of PR on at least one occasion were 22%
less likely to die than those with no record; adjusted hazard ratio
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Fig. 1 Patients with COPD from the THIN database according to pulmonary rehabilitation
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(aHR) 0.78 (95% CI 0.69–0.88) [Table 3]. Analysing only those with
an MRC of 3 or worse showed a similar survival effect, aHR 0.76
(95% CI 0.64–0.89). Survival was not affected by year of diagnosis
or by GOLD airﬂow obstruction (where % predicted spirometry
was available), data not shown. A secondary survival analysis from
the date of diagnosis emphasised the above ﬁnding. Patients with
recorded PR were 66% less likely to die than those with no
recorded PR, aHR 0.34 (95% CI 0.31–0.39).
DISCUSSION
The majority of patients diagnosed with COPD have no coded
record of pulmonary rehabilitation in their primary care records,
even amongst those with an MRC dyspnoea score of 3 or worse.
This is despite pulmonary rehabilitation being one of the most
effective interventions in patients with COPD and ingrained in
guidelines. Several factors appear to have inﬂuenced PR recording
including younger age at diagnosis, better socioeconomic status,
worse breathlessness score, current smoking status, and more
comorbidities-all of which are associated with having a record of
PR. An interesting survival beneﬁt was seen among those with a
record of PR compared to those without a record but PR record
was associated with better coding of other COPD treatments,
suggesting better package of COPD care generally.
With both the NICE COPD and the BTS pulmonary rehabilitation
guidelines recommending PR to all eligible patients with COPD,
the recording of PR here, in primary care records is disappointingly
low.1,2 There are several factors that may be important to consider
in relation to recording with PR, recently highlighted as crucial
barriers to overcome.18 They include healthcare professional
awareness of the referral criteria, referral pathway and the likely
beneﬁts of PR together with patient awareness and willingness to
be referred and attend. Further, availability of PR and distance to
travel may be further issues. The recent National COPD audit,
pulmonary rehabilitation workstream in England and Wales
determined spaces at each PR site and the precedent mapping
exercise identiﬁed over 230 programmes and their geographical
location.11 How that then meets the needs of the COPD
Table 1. Univariate and Multivariate logistic regression for patients with COPD who have recorded pulmonary rehabilitation compared with who
have not recorded pulmonary rehabilitation
Recorded PR 3542 Not recorded PR 30,982 uOR aOR (95%CI) P value
Age at the diagnosis (years)
≤50 271 (9.86) 2477 (90.14) 0.79 0.82 (0.70–0.97)
51–60 782 (12.07) 5695 (87.93) 1 <0.0001
61–70 1310 (11.96) 9643 (88.04) 0.98 1.01 (0.91–1.12)
≥71 1179 (8.22) 13,167 (91.78) 0.65 0.60 (0.53–0.76)
Gender
Male 1849 (10.00) 16,648 (90.00) 1 0.757
Female 1693 (10.56) 14,334 (89.44) 1.06 0.99 (0.92–1.07)
Townsend category
I least deprived 550 (9.97) 4968 (90.03) 1
II 577 (9.71) 5368 (90.29) 0.97 0.89 (0.78–1.02) <0.0001
III 709 (10.20) 6245 (89.80) 1.02 0.79 (0.70–0.91)
IV 849 (10.16) 7153 (89.39) 1.07 0.71 (0.63–0.81)
V most deprived 779 (10.95) 6336 (89.05) 1.11 0.61 (0.54–0.70)
Missing 78 (7.88) 912 (92.12) 0.77 0.59 (0.45–0.77)
MRC scorea
MRC 1 223 (3.20) 6743 (96.80) 1
MRC 2 880 (7.81) 10,382 (92.19) 2.56 2.41 (2.06–2.81) <0.0001
MRC 3 1230 (20.02) 4915 (79.98) 7.56 6.43 (5.51–7.50)
MRC 4 715 (23.99) 2266 (76.01) 9.54 8.01 (6.77–9.47)
MRC 5 112 (17.95) 512 (82.05) 6.61 5.96 (4.58–7.76)
Not recorded 382 (5.84) 6164 (94.16) 1.87 1.47 (1.23–1.76)
Smoking statusa
Never 279 (3.24) 8324 (96.76) 0.32 0.28 (0.25–0.32)
Ex 1696 (9.44) 16,275 (90.56) 1 <0.0001
Current 1486 (18.82) 6334 (81.18) 2.22 2.62 (2.41–2.86)
Unknown 99 (66.89) 49 (33.11) 19.38 25.95 (17.00–39.62)
Charlson comorbidities index
1 304 (2.42) 12,247 (97.58) 1
2 1494 (12.43) 10,522 (87.57) 5.72 5.40 (5.13–6.63) <0.0001
3 920 (15.52) 5006 (84.48) 7.40 7.23 (6.64–8.75)
≥4 824 (20.44) 3207 (79.56) 10.35 10.44 (9.17–12.23)
a For Recorded PR: MRC and smoking status was taken 15 months prior to the date of ﬁrst PR record. Not recorded: it was taken 15 months prior to the index
time point-875 days plus date of diagnosis
uOR unadjusted odds ratio, aOR adjusted odds ratios of recorded PR
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population and people with other chronic respiratory disease is
required, not least as PR can be repeated.
Factors that determine attendance and drop-out of patients in
pulmonary rehabilitation are important to identify as good
attendance facilitates the optimal functional beneﬁts.19–22 Those
associated with non-adherence include lower social class, social
deprivation, and current smoking.20,23,24 However, irrespective of
age,5,6 current smoking,25 or comorbidities,10 functional and
psychological beneﬁts can be achieved with PR and would
therefore should not be barriers to referral.1 Indeed, PR promotes
lifestyle change and as such may facilitate smoking cessation.25 It
is thus reassuring that in our study, we report better recording of
PR in those with current smoking status or with more
comorbidities. One possible explanation that the recording
increases with higher comorbidities index is that patients with
higher comorbidities might visit their GP more frequently than
lower comorbidities patients and therefore a greater opportunity
for them to be referred. Additionally, these patients might feel
worse due to their co-morbid illness and therefore the GP might
be more likely refer them more to PR programme. Similarly,
current smokers had better PR recording than others and as the
PR programme often consists of smoking cessation the GP could
use PR as an opportunity to facilitate and reinforce smoking
cessation. However, recording was worse in those with lower
socioeconomic status or older age at diagnosis. Compared to
those patients who were assessed for PR in the national PR audit,26
the socio-demographic characteristics of this study population
with record of PR in their primary care record were broadly similar.
Systematic reviews have demonstrated improved survival for
patients with COPD undergoing PR after an acute exacerba-
tion,14,27 such that the meta-analysis of PR following an
exacerbation, the OR for mortality was 0.28; 95% CI 0.10 to
0.84.14,27 This was more favourable than our reported OR of 0.78
(0.69–0.88) for all recording of PR but the difference perhaps
reﬂects the post exacerbation period of instability and generally
greater increased mortality at this time. In the standard PR,
delivered at clinical stability, the evidence from published
literature of survival beneﬁt is weaker as there was only data
from two small randomised clinical trials where survival was a
secondary outcome in both publications.15,16 One study compared
Table 2. Univariate and Multivariate logistic regression for patients with COPD who have declined pulmonary rehabilitation compared with who
have recorded pulmonary rehabilitation
Declined PR 1665 Recorded PR 3542 uOR aOR (95%CI) P value
Age at the diagnosis (years)
≤50 113 (29.43) 271 (70.57) 0.87 0.80 (0.62–1.03) 0.007
51–60 371 (32.18) 782 (67.82) 1
61–70 615 (31.95) 1310 (68.05) 0.98 1.04 (0.89–1.23)
≥71 566 (32.44) 1179 (67.56) 1.01 1.22 (1.03–1.46)
Gender
Male 857 (31.67) 1849 (68.33) 1 0.503
Female 808 (32.31) 1693 (67.69) 1.02 1.03 (0.91–1.16)
Townsend category
I least deprived 179 (24.55) 550 (75.45) 1 <0.0001
II 244 (29.72) 577 (70.28) 1.29 1.36 (1.08–1.71)
III 322 (31.23) 709 (68.77) 1.39 1.44 (1.15–1.79)
IV 430 (33.62) 849 (66.38) 1.55 1.59 (1.29–1.96)
V most deprived 446 (36.41) 779 (63.59) 1.75 1.81 (1.46–2.25)
Missing 44 (36.07) 78 (63.93) 1.73 1.72 (1.13–2.60)
MRC scorea
MRC 1 148 (39.89) 223 (60.11) 1 <0.0001
MRC 2 544 (38.20) 880 (61.80) 0.93 0.89 (0.70–1.29)
MRC 3 591 (32.45) 1230 (67.55) 0.72 0.67 (0.53–0.85)
MRC 4 279 (28.07) 715 (71.93) 0.58 0.53 (0.41–0.68)
MRC 5 47 (29.56) 112 (70.44) 0.63 0.57 (0.38–0.85)
Not recorded 56 (12.79) 382 (87.21) 0.22 0.21 (0.14–0.30)
Smoking statusa
Never 97 (25.80) 279 (74.20) 0.83 0.84 (0.65–1.09) <0.0001
Ex 709 (29.48) 1696 (70.52) 1
Current 834 (36.23) 1468 (63.77) 1.35 1.38 (1.21–1.58)
Unknown 25 (20.16) 99 (79.84) 0.60 0.70 (0.44–1.12)
Charlson comorbidities index
1 149 (32.89) 304 (67.11) 1 0.105
2 673 (31.06) 1494 (68.94) 0.91 0.95 (0.76–1.19)
3 410 (30.83) 920 (69.17) 0.90 0.95 (0.75–1.20)
≥4 433 (34.45) 824 (65.55) 1.07 1.14 (0.90–1.45)
a MRC and smoking status was taken 15 months prior to the date of ﬁrst recorded or declined PR for both groups
uOR unadjusted odds ratio, aOR adjusted odds ratios of recorded decline PR
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standard PR to education only with a non-signiﬁcant ﬁnding but
generally indicating better survival in the PR group.16 The other
reported better survival in those who received standard PR (92
patients) compared to a group who did not, in the following year
(P = 0.032).15 Deliberately denying patients access to PR in one
arm of a randomised control trial to assess survival is not an
option in a government funded healthcare system like the UK,
given the overwhelming evidence PR delivers in other outcomes.
Moreover, although we tried to assess the impact of the most
potential confounders (comorbidities, smoking status, MRC
dyspnoea score), unmeasured confounders such as level of
physical activity were not accounted for in the analyses. We
cannot tell whether adjusting for these unmeasured confounders
could account for the survival beneﬁts.
Mechanisms as to how PR might improve mortality may be
through improving physical activity.28 Physical activity is a strong
predictor of survival in both the general population and in
patients with COPD.29,30 Multidisciplinary PR aims to improve
exercise tolerance, muscle strength, as well as psychological
barriers and hence impact on physical activity.31 A study showed
an overall improvement in the multi-composite BODE index score
in patients attending PR after 3 months compared to baseline.32
Further, the goals of PR are a longer-term lifestyle change, that
therefore likely impact further on survival.1 Improvements in
depression and greater disease understanding from PR may also
be relevant.1 An alternative plausible explanation for better
survival that is likely is that patients with PR recorded are also
receiving a more comprehensive COPD package of care in other
aspects, demonstrated in the better coding for ﬂu vaccination and
smoking cessation that we used as surrogate markers here. Finally
it is possible that health inequalities is a possible explanation for
these ﬁndings, as patients from lower socioeconomic class tend to
be less educated in general and about their disease, have less
medication adherence, less access to health care than the patients
from higher social class,33,34 and all of these factors are likely to
impact survival.
A strength of this study is this primary care data is large,
representative sample of patients within the UK with limited
missing data. Patients with COPD were included from 2004
onwards when the Quality and Outcomes Frameworks (QOF) was
established and therefore the diagnoses of COPD are more likely
to be reliant on spirometry. However, the possibility of mis-
diagnosis of COPD remains.35,36 A 2004 start for this analysis also
coincides with the NICE COPD guidelines being published which
recommended PR for patients diagnosed with COPD with a MRC
dyspnoea score of 3 or worse.4 Large differences exist among
pulmonary rehabilitation programmes worldwide,37 making it is
difﬁcult to generalise wider than the UK processes of referral and
healthcare delivery. Importantly, the GP research database does
not record information on adherence, attendance, and core
outcome measures, which can vary markedly. The use of PR Read
codes in primary care data included three different codes
“assessed”, “referred”, and “completed” were rarely used all
together to describe a patient PR experience, generally just one
of these were used. Therefore the three codes were combined to
represent an episode of PR. However it is possible for a patient to
be assessed or referred but not to have completed PR which
would if anything move our survival results towards the null
hypothesis. Although The Health Improvement Network (THIN)
primary care data is used extensively for research, its primary
purpose is for clinical care and it is possible the clinician discussed
and recorded the PR decision as free text or had offered the PR
and the patient declined it and then did not record the outcome.
Both of these would bias the results towards the null hypothesis.
Recording of data in general practice has been emphasised as a
core competency in the Royal College of General Practitioners
training curriculum, 2016.38 Moreover, introduction of the QOF has
been suggested previously to improve the quality of recording.39
It is important to consider that some variables used in these
analyses can change from the last recorded coded entry in
records. An example of this is smoking status which when self-
reported, also has limitations.. A patients’ health-related behaviour
can also effect the patients participation and completion in the PR
programmes.40 PR referral may have stemmed from hospital
physicians or community teams distinct from the GP surgery.37
However, the entry for PR still should be recorded in the patients’
record whatever its source. And where it is not recoded, should
prompt a clinician to ask at the next review and record then. It
appears this population with missing data have more severe
COPD as they more likely to be referred for PR than those with
MRC score 1 and have a worse survival as well. The imputed
anchor point that we used for the survival analysis in those who
Table 3. Mutually adjusted hazard ratios of patients who have
recorded pulmonary rehabilitation (n= 2964) to those have not
recorded (n= 24,424)
aHR 95% CI
Recorded PR 0.78 0.69–0.88
No record PR 1
Age at the diagnosis (years)
< 50 0.51 0.39–0.66
50–60 1
60–70 1.65 1.45–1.87
> 70 3.18 2.82–3.59
Gender
Male 1
Female 0.78 0.73–0.83
Townsend category
I least deprived 1
II 0.99 0.88–1.11
III 1.08 0.97–1.21
IV 1.06 0.95–1.19
V most deprived 1.06 0.94–1.19
Missing 0.70 0.54–0.92
MRC scorea
MRC 1 1
MRC 2 1.54 1.36–1.75
MRC 3 2.36 2.07–2.69
MRC 4 3.75 3.26–4.31
MRC 5 5.42 4.50–6.54
Not recorded 2.96 2.61–3.37
Smoking statusa
Never 0.91 0.84–0.98
Ex 1
Current 1.18 1.07–1.29
Unknown 0.99 0.58–1.68
Charlson comorbidities index
1 1
2 1.13 1.03–1.23
3 1.24 1.13–1.37
≥4 1.51 1.36–1.69
a For Recorded PR: MRC and smoking status was taken 15 months prior to
the date of ﬁrst PR record. Not recorded: it was taken 15 months prior to
the index time point-875 days plus date of diagnosis
aHR adjusted hazard ratio, CI conﬁdence interval
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did not have PR record is a limitation but is preferable to using
diagnosis date which exaggerates the survival difference-anyone
who dies within a short period from diagnosis would be unlikely
to have PR by this very nature.
Clinical implication and conclusion
Despite the proven effectiveness of PR for patients with COPD, it
was not recorded for the majority of patients with COPD in UK
primary care records. Younger age at diagnosis, better socio-
economic status, worse breathlessness score, current smoking,
and more comorbidities were associated with improved recording
of PR. Further, we determined a survival beneﬁt in favour of those
with a record of PR, likely as part of a better package of COPD care.
This study adds to the understanding of the characteristics of the
patients with a PR record and future research needs to gain a
better understanding of any barriers that prevent patients
attending or being referred.
METHODS
Data source and study population
THIN is a large nationally representative database of primary care records
in the UK.41 Patients with COPD were extracted for the period up to May
22, 2014; patients with a new coded diagnosis of COPD made since
January 1, 2004 were included. Patients were excluded whose recorded
death or PR preceded recorded COPD diagnosis.
Ethical approval
Ethical approval for the study was provided by the Cegedim Strategic Data
Medical Research Scientiﬁc Review Committee (14-066). The methods were
performed in accordance with relevant regulations and guidelines.
Pulmonary rehabilitation coding
Patients were classiﬁed according to the following:
● “Recorded PR” group: at least one coding of being assessed, referred,
or having completed PR records on at least one occasion; the ﬁrst
recording of any of these was used if the patient had more than one
coding.
● “Declined PR” group, those who have only a code of declining PR.
● “Not recorded PR”: those who have no code of PR
Demographics
The identiﬁed patient demographic variables included age at diagnosis
(four categories: ≤50, 51–60, 61–70, and ≥71 years), gender, quintile of the
Townsend Index of Deprivation (socioeconomic status),42 Medical Research
Council (MRC) dyspnoea score,43 smoking status (current, ex, never or not
recorded), and the Charlson Comorbidities Index (that preceded and
included date of diagnosis of COPD divided into four categories: 1, 2, 3, or,
4 or more).44
There were two analyses conducted using logistic regression: a
comparison of demographic and disease severity between those who
have a code of recorded PR vs. those with no recorded PR, and the same
characteristics between those with coded declined PR against those with
recorded PR were compared. For recorded or declined PR groups, MRC
score, and smoking status was used within 15 months prior to the ﬁrst PR
code. The median time from diagnosis with COPD to recorded PR group
was determined. This was added to the diagnosis date in those patients
without a recorded PR. Using this new date, MRC dyspnoea score, and
smoking status were recorded from within 15 months prior to this time.
We performed a further review on two other aspects of COPD care
according to recorded PR or not to put in context, namely smoking
cessation coding in the current smokers and ﬂu vaccination.
Survival analysis
The Cox regression model was used for a multivariate survival analysis
between the recorded PR and not recorded PR, adjusting for demographic,
smoking status, MRC score, and level of comorbidities within the model.
The start date was the date of the ﬁrst PR record for recorded PR group
and was the input date of diagnosis plus the median time from diagnosis
to PR in the not recorded PR group. In addition, for the survival analyses,
patients who did not have a PR record and had then less person-time than
the median time from date of diagnosis to date of survival were excluded.
The end date was the date of death, the date of leaving the dataset, or end
date of data collection (May 22, 2014). Person time values were all
calculated with the proper person time approach for each group. We did
sensitivity analysis that excluded patients with MRC 1 and 2 and we
additionally looked at survival from date of diagnosis.
All statistical analyses were performed using the Stata version 13 soft-
ware (StataCorp LP, college station, TX, USA). P-values were determined
using likelihood ratio test.
Data availability
The Health Improvement Network (THIN) was the source for this work.
Permission was granted following ethical approval by the Cegedim
Strategic Data Medical Research Scientiﬁc Review Committee (14-066).
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